News tagged with bone metastases
What wakes dormant tumor cells
Prostate tumor cells can be lulled to sleep by a factor released by bone cells, according to a study published online this week in the Journal of Experimental Medicine. Disease recurs in up to half of prostate cancer patien ...
Nov 28, 2011 |
not rated yet |
0
Denosumab delays development of prostate cancer bone metastasis
An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The study, receiving Online First ...
Nov 16, 2011 |
not rated yet |
0
More radionuclide therapy is better for prostate cancer patients
For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November ...
Nov 01, 2011 |
not rated yet |
0
Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Stockholm, Sweden: Many prostate cancer patients develop bone metastases, and controlling the pain these cause can be difficult. Now the first large randomised Phase III trial of a bisphosphonate drug in these patients has ...
Sep 25, 2011 |
4 / 5 (1) |
0
New bone-targeting drug delays onset of metastases in hormone-resistant prostate cancer patients
Stockholm, Sweden: Inhibiting a protein involved in bone metabolism can delay the onset of the bone metastases which are common in men with a particular form of prostate cancer, a researcher will tell the 2011 European Multidisciplinary ...
Sep 25, 2011 |
not rated yet |
0
First Phase III trial of an alpha-pharmaceutical
Until recently, options for patients with bone metastases from advanced prostate cancer have been very limited. But now the first Phase III study of an alpha-pharmaceutical in these patients has shown that it can prolong ...
Sep 23, 2011 |
not rated yet |
0
Bayer flags strong results of prostate cancer drug
German chemical and pharmaceutical group Bayer said Monday that its Alpharadin treatment for prostate cancer has shown positive results in advanced trials.
Jun 06, 2011 |
not rated yet |
0
Bone drug zoledronic acid may help prevent spread of early lung cancer
A drug that is currently used to help treat bone metastases in patients with lung cancer could also be useful at an earlier stage of treatment, to prevent the cancer from spreading in the first place, Italian researchers ...
Feb 25, 2011 |
5 / 5 (1) |
0
New drug for use in bone scans approved
The FDA has approved a New Drug Application (NDA) from the National Cancer Institute (NCI), part of the National Institutes of Health, for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone ...
Feb 01, 2011 |
not rated yet |
0
Denosumab delayed time to first skeletal-related side effect
For patients with breast cancer and bone metastases, denosumab delayed skeletal-related side effects five months longer compared to those on zoledronic acid, according to results presented at the 33rd Annual CTRC-AACR San ...
Dec 10, 2010 |
not rated yet |
0
Novel cancer drug has potential, study reports
(PhysOrg.com) -- Monthly injections of the drug in breast cancer patients whose disease had spread to the bone helped reduce pain and prevent complications with less toxicity than current treatments.
Nov 12, 2010 |
5 / 5 (1) |
0
|
Researchers find pathway that drives spread of pediatric bone cancer in preclinical studies
Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer.
Oct 25, 2010 |
not rated yet |
0
Whole body MRI is highly accurate in the early detection of breast cancer metastases
Whole body magnetic resonance imaging (MRI) should be the imaging modality of choice for the detection of breast cancer metastases (when the cancer has spread beyond the breast) as it is highly accurate and can detect bone ...
May 06, 2010 |
5 / 5 (2) |
1
Autologous stem cell transplantation for soft tissue sarcoma: insufficient research into therapy
Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some of the patient's own (autologous) ...
Dec 08, 2009 |
not rated yet |
0
Killing cancer like a vampire slayer
Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die.
Sep 17, 2009 |
not rated yet |
0
